Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome - PubMed (original) (raw)
Clinical Trial
. 2005 Jun;115(6):1254-9.
doi: 10.1016/j.jaci.2005.03.047.
Affiliations
- PMID: 15940143
- DOI: 10.1016/j.jaci.2005.03.047
Clinical Trial
Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome
Mirva Viljanen et al. J Allergy Clin Immunol. 2005 Jun.
Abstract
Background: The immunomodulating mechanisms of Lactobacillus GG (LGG) and other probiotics are poorly understood.
Objective: We studied in vivo the immunologic effects of probiotics in infants with atopic eczema-dermatitis syndrome (AEDS) and cow's milk allergy (CMA).
Methods: Two hundred thirty infants with AEDS and suspected CMA received, concomitant with elimination diet, either LGG, a mixture of 4 probiotic strains (MIX), or placebo for 4 weeks. All available paired pretreatment and posttreatment plasma samples (n = 132) were analyzed for concentrations of IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma, soluble intercellular adhesion molecule 1, soluble E-selectin, TGF-beta1, TGF-beta2, and C-reactive protein.
Results: In infants with IgE-associated AEDS, treatment with LGG induced higher C-reactive protein levels than in the placebo group (geometric mean, 0.83 microg/mL [95% CI, 0.56-0.81] vs 0.42 microg/mL [95% CI, 0.27-0.65]; P = .021). Concomitantly, IL-6 levels increased after treatment with LGG ( P = .023) but not with MIX or placebo. Soluble E-selectin levels were higher after probiotic than after placebo treatment in infants with IgE-mediated CMA (LGG geometric mean, 86.7 ng/mL [95% CI, 75.2-100]; MIX geometric mean, 91.6 ng/mL [95% CI, 74.8-111.9]; and placebo geometric mean, 64.9 ng/mL [95% CI, 53-79.3]; analysis of covariance, P = .035; LGG vs placebo, P = .023; MIX vs placebo, P = .020). Use of MIX induced an increase in plasma IL-10 levels ( P = .016).
Conclusion: Probiotics induced systemically detectable low-grade inflammation, which might explain the clinical effects of probiotics in AEDS and CMA.
Similar articles
- Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy.
Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E. Pohjavuori E, et al. J Allergy Clin Immunol. 2004 Jul;114(1):131-6. doi: 10.1016/j.jaci.2004.03.036. J Allergy Clin Immunol. 2004. PMID: 15241356 Clinical Trial. - Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants.
Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Viljanen M, et al. Pediatr Allergy Immunol. 2005 Feb;16(1):65-71. doi: 10.1111/j.1399-3038.2005.00224.x. Pediatr Allergy Immunol. 2005. PMID: 15693914 Clinical Trial. - Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial.
Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Viljanen M, et al. Allergy. 2005 Apr;60(4):494-500. doi: 10.1111/j.1398-9995.2004.00514.x. Allergy. 2005. PMID: 15727582 Clinical Trial. - Probiotics in the treatment and prevention of allergies in children.
Savilahti E. Savilahti E. Biosci Microflora. 2011;30(4):119-28. doi: 10.12938/bifidus.30.119. Epub 2011 Nov 17. Biosci Microflora. 2011. PMID: 25045317 Free PMC article. Review. - [Probiotics in allergic diseases of childhood].
Hauer A. Hauer A. MMW Fortschr Med. 2006 Aug 31;148(35-36):34-6. MMW Fortschr Med. 2006. PMID: 16995361 Review. German.
Cited by
- Role of Probiotics in health improvement, infection control and disease treatment and management.
Amara AA, Shibl A. Amara AA, et al. Saudi Pharm J. 2015 Apr;23(2):107-14. doi: 10.1016/j.jsps.2013.07.001. Epub 2013 Jul 18. Saudi Pharm J. 2015. PMID: 25972729 Free PMC article. Review. - Probiotics in the treatment and prevention of allergy in children.
Savilahti E, Kukkonen K, Kuitunen M. Savilahti E, et al. World Allergy Organ J. 2009 May;2(5):69-76. doi: 10.1097/WOX.0b013e3181a45ee5. World Allergy Organ J. 2009. PMID: 23283013 Free PMC article. - Probiotic therapy as a novel approach for allergic disease.
Toh ZQ, Anzela A, Tang ML, Licciardi PV. Toh ZQ, et al. Front Pharmacol. 2012 Sep 21;3:171. doi: 10.3389/fphar.2012.00171. eCollection 2012. Front Pharmacol. 2012. PMID: 23049509 Free PMC article. - Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults.
Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S, Kautiainen H, Julkunen I, Vapaatalo H, Korpela R. Kekkonen RA, et al. World J Gastroenterol. 2008 Apr 7;14(13):2029-36. doi: 10.3748/wjg.14.2029. World J Gastroenterol. 2008. PMID: 18395902 Free PMC article. Clinical Trial. - Effect of the Lactococcus Lactis 11/19-B1 Strain on Atopic Dermatitis in a Clinical Test and Mouse Model.
Suzuki T, Nishiyama K, Kawata K, Sugimoto K, Isome M, Suzuki S, Nozawa R, Ichikawa Y, Watanabe Y, Suzutani T. Suzuki T, et al. Nutrients. 2020 Mar 14;12(3):763. doi: 10.3390/nu12030763. Nutrients. 2020. PMID: 32183266 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials